# EDGAR Filing Document

**Accession Number:** 0000744452
**File Stem:** 0001892613-26-000006
**Filing Date:** 2026-6
**Character Count:** 19628
**Document Hash:** 45c85a1db9978650de679d0e34e91a5d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001892613-26-000006.hdr.sgml**: 20260617

**ACCESSION NUMBER**: 0001892613-26-000006

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260617

**DATE AS OF CHANGE**: 20260617

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNB PLUS CORP.
- **CENTRAL INDEX KEY:** 0000744452
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-TESTING LABORATORIES [8734]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 592262718
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-78682
- **FILM NUMBER:** 261100145

**BUSINESS ADDRESS:**
- **STREET 1:** 25 HEALTH SCIENCES DRIVE
- **CITY:** STONY BROOK
- **STATE:** NY
- **BUSINESS PHONE:** 631-240-8800

**MAIL ADDRESS:**
- **STREET 1:** 25 HEALTH SCIENCES DRIVE
- **CITY:** STONY BROOK
- **STATE:** NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** APPLIED DNA SCIENCES INC
- **DATE OF NAME CHANGE:** 20021218

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROHEALTH MEDICAL TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 20010504

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DCC ACQUISITION CORP
- **DATE OF NAME CHANGE:** 19990211
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Comstock MultiChain Fund, L.P.
- **CENTRAL INDEX KEY:** 0001892613

**ORGANIZATION NAME:**
- **EIN:** 873298145
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 85 SHERMAN TURNPIKE
- **CITY:** REDDING
- **STATE:** CT
- **ZIP:** 06896
- **BUSINESS PHONE:** 203-966-3896

**MAIL ADDRESS:**
- **STREET 1:** 85 SHERMAN TURNPIKE
- **CITY:** REDDING
- **STATE:** CT
- **ZIP:** 06896

### Attached PDF Documents

**Attachment 1:** `exh99_jointfilingagmtjun26.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**BNB PLUS CORP.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Richard Shorten**<br>1209 Orange Street<br>Wilmington DE 19801<br>203 208 8631

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/12/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Comstock MultiChain Fund, L.P.** | Name of reporting person<br>**Comstock MultiChain Fund, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1178402.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1178402.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** 1,178,402 shares of Common Stock underlying the shares of the issuer's Series B1 Preferred Stock and Series B2 Preferred Stock (collectively, the Preferred Stock) owned by the Reporting Persons, which represents less than the entirety of the shares of Common Stock underlying the Preferred Stock. Each series of the Preferred Stock is convertible to Common Stock on a one-share-for-one-share basis. The Preferred Stock is convertible at any time by the holder thereof.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Comstock Multichain GP LLC** | Name of reporting person<br>**Comstock Multichain GP LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CONNECTICUT** | Citizenship or place of organization<br>**CONNECTICUT** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1178402.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1178402.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Silvermine Capital Advisors, LLC** | Name of reporting person<br>**Silvermine Capital Advisors, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CONNECTICUT** | Citizenship or place of organization<br>**CONNECTICUT** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1178402.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1178402.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Shorten Richard Lee Jr.** | Name of reporting person<br>**Shorten Richard Lee Jr.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1178402.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1178402.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | Aggregate amount beneficially owned by each reporting person<br>**1178402.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
BNB PLUS CORP.

**(c) Address of Issuer's Principal Executive Offices:**
25 HEALTH SCIENCES DRIVE, STONY BROOK, NY, 11790

**Item 4. Purpose of Transaction**

Item 4 of the Schedule 13D is hereby amended to add the following:

Comstock has acquired the new securities for the purpose of investment and to restructure a portion of its existing holdings of the Issuer's securities into the convertible Preferred Stock on the terms agreed with the Issuer.   In addition, an affiliate of the Reporting Persons has been retained by the Issuer's board of directors to conduct a strategic review of the Issuer's businesses, including its biotech business and its digital asset treasury business, with a view to consummating a restructuring or one or more strategic transactions to realize shareholder value. Such strategic review may involve recommendations of combinations, partnerships, investments or other similar transactions, including transactions that may involve such affiliate as a principal party.

The Reporting Persons may change their intentions with respect to any and all matters referred to in this Item 4.  They may also take steps to explore and prepare for various plans and actions, and propose transactions, before forming an intention to engage in such plans or actions or proceed with such transactions.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and depending upon various factors, including without limitation, the Issuer's financial position and strategic direction, the outcome of any discussions referenced above, overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor (i) to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer, including through transactions involving the Common Stock or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer in the open market or in private transactions, including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as the Reporting Persons may deem advisable or (ii) to enter into transactions that increase or hedge their economic exposure to the Common Stock without affecting their beneficial ownership of the Common Stock.  In addition, the Reporting Persons may, at any time and from time to time, (x) review or reconsider their position or change its purpose or formulate plans or proposals with respect thereto and (y) consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13 D is hereby amended and restated in its entirety as follows:

5(a)

1,178,402, which consists of shares of Common Stock underlying the Preferred Stock. The Preferred Stock and the Warrants (as defined below) each contain a beneficial ownership limitation so that in no event shall the holder's beneficial ownership exceed 9.99% (the "Blocker"). Accordingly, the number of shares beneficially owned by Comstock does not include 13,024 shares of Common Stock underlying the Preferred Stock and 2,462,052 of Common Stock underlying the Warrants because the Blocker limits Comstock from exercising for any additional shares of Common Stock.

Comstock is the record holder of Series E Warrants that are exercisable for 1,310,242 shares of Common Stock (the "Common Stock Warrants").

Comstock also owns 641,426 shares of Series B-1 Preferred Stock. In addition, Comstock owns 550,000 shares of Series B-2 Preferred Stock and 1,151,810 Series B-2 Prefunded Preferred Stock Purchase Warrant shares (the "Prefunded Warrants" and, together with the Common Stock Warrants, the "Warrants"). Each share of the Preferred Stock is convertible to Common Stock on a one-share-for-one-share basis; and each Pre-Funded Warrant is exercisable into Preferred Stock on a one-to-one basis. The Preferred Stock is convertible, and the Pre-Funded Preferred Stock Warrants are exercisable, at any time by the holder thereof, subject to the Blocker.

Comstock is the record holder of the shares of the Preferred Stock and the Warrants.  Silvermine Capital Advisors, LLC, as the investment advisor of Comstock, has investment discretion over the shares of Preferred Stock directly held and the shares of Common Stock and Preferred Stock underlying the Warrants.

Each of Silvermine Capital Advisors, LLC, Comstock GP, and Richard Shorten disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein,  if any.

**(b)**
5(b)

9.99%, based on 11,795,820 shares of Common Stock outstanding, as confirmed by the Issuer.

**(c)**
5(c)

Pursuant to the Warrant Inducement Exchange Agreement entered into with the Company (the "Inducement Agreement"), Comstock (1) exercised 195,784 shares of the Series E Warrants issued to it in the October 2025 PIPE, at an exercise price of $3.82 per share of Common Stock, in consideration for the Issuer issuing to Comstock 641,426 shares of Series B-1 Preferred Stock of the Issuer; and (2) delivered to the Issuer all pre-funded warrants issued to Comstock in the 2025 PIPE in exchange for the Issuer issuing Series B-2 Prefunded Preferred Stock Purchase Warrants to Comstock.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of the Schedule 13 D is hereby amended and restated in its entirety as follows:

The Reporting Persons' response to Items 4 and 5 is incorporated by reference into this Item 6.

Comstock holds Preferred Stock and Warrants, including but not limited to Pre-Funded warrants, to purchase shares of Common Stock and Preferred Stock, which are exercisable at any time (including within 60 days), subject to the Blocker. Only a portion of the shares of Common Stock underlying the Preferred Stock are, however, included in the beneficial ownership information reported herein because they contain a beneficial ownership limitation so that in no event shall the holder's beneficial ownership exceed 9.99%, and therefore the number of shares beneficially owned does not include 13,024 shares of Common Stock underlying the Preferred Stock and 2,462,052 shares of Common Stock underlying the Warrants as the Blocker limits Comstock from exercising for any additional shares of Common Stock.

Except as described herein, the Reporting Persons have no contracts, arrangements, understandings or relationships with any person with respect to any securities of the Issuer. Comstock is party to the Inducement Agreement and related documents described herein. An affiliate of a Reporting Person has also entered into an engagement with the Issuer's board of directors to conduct a strategic review of the Issuer's businesses, and such review may involve recommendations of combinations, partnerships, investments or other similar transactions, including transactions that may involve such affiliate as a principal party.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Comstock MultiChain Fund, L.P.

**Signature:** /s/ Richard L. Shorten

**Name/Title:** Richard L. Shorten/Authorized Signatory

**Date:** 06/17/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Comstock Multichain GP LLC

**Signature:** /s/ Richard Shorten

**Name/Title:** Richard Shorten/Authorized Signatory

**Date:** 06/17/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Silvermine Capital Advisors, LLC

**Signature:** /s/ Richard L. Shorten

**Name/Title:** Richard L. Shorten/Managing Member

**Date:** 06/17/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Shorten Richard Lee Jr.

**Signature:** /s/ Richard Lee Shorten Jr.

**Name/Title:** Richard L Shorten Jr./Individual

**Date:** 06/17/2026